Raynaud's phenomenon: Infrared functional imaging applied to diagnosis and drugs effects

International Journal of Immunopathology and Pharmacology

Volumn 15, Issue 1, 2002, Pages 41-52

  Merla, A ^a   Romani, G L ^a   Di Luzio, S ^a   Di Donato, L ^a   Farina, G ^a   Proietti, M ^a   Pisarri, S ^a   Salsano, Felice ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Infrared functional imaging; N acetylcysteine; Raynaud's phenomenon; Scleroderma

Indexed keywords

ACETYLCYSTEINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY TEMPERATURE; CAPILLAROSCOPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLD STRESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FEMALE; HUMAN; INFRARED PHOTOGRAPHY; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; THERMOGRAPHY; THERMOREGULATION; TREATMENT OUTCOME; VASODILATATION; WARMING;

EID: 0036212129     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200201500106     Document Type: Article

References (54)

1. Raynaud's phenomenon: A proposal for classification
2. Vasospastic diseases
3. Raynaud's phenomenon
4. Raynaud's phenomenon
5. Geografic variation in the prevalence of Raynaud's phenomenon - Charleston, SC, USA vs. Tarentaise, Savoie, France
6. Raynaud's phenomenon: Its relevance to scleroderma
7. Criteria for the classification of early systemic sclerosis
8. When is Scleroderma really scleroderma?
9. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon
10. The effect of the calcium-entry blocker nifedipine on cold-induced digital vasospasm: A double-blind crossover study versus placebo
11. Controlled double-blinded trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon
12. Nifedipine in Raynaud's phenomenon: Relationship between immediate, short term and long term effects
13. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease
14. Nifedipine in the treatment of idiopathic Raynaud's syndrome
15. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
16. Losartan therapy for RPand scleroderma
17. Treatment of RPwith the selective serotonine reuptake Inhibitor fluoxetine
18. Comparison of intravenous infusions of Iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: A double blind randomised study
19. Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PG12;)
20. Oral Iloprost as a treatment for Raynaud's syndrome: A double blind multicentre placebo controlled study
21. Treatment of Raynaud's phenomenon with intravenous prostaglandin PGE1 alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis
22. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study
23. N-acetylcysteintentiates platelet inhibition by endothelium-derived relaxing factor
24. N-acetylcysteine and captopril inhibit but S-nitroso-N-acetylcysteine stimulates human neutrophil free radical production
25. The role of glutathione status in the protection against ischaemic and reperfusion damage: Effects of N-acetylcysteine
26. Oxygen free radicals and myocardiol damage protective role of thiol-containing agents
27. Pharmacokinetics and bioavailability of reduced and oxidized N-Acetylcysteine
28. Measurement of clinical change in progressive systemic sclerosis: A 1 year double-blind placebo-controlled trial of N-acetylcysteine
29. Intravenous N-Acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study
30. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis
31. Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon
32. Thermography and nailfold capillaroscopy as noninvasive measures of circulation in children with Raynaud's phenomenon
33. Measurement of cold challenge response in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis
34. The distal-dorsal difference as a possible predictor of secondary Raynaud's phenomenon
35. Thermographic parameters in the diagnosis of Secondary Raynaud's Phenomenon
36. Combined approach to the initial stage Raynaud's phenomenon diagnosis by means of dynamic digital telethermography, capillaroscopy and pletismogmphy: Preliminary findings
37. Infrared functional imaging applied to the study of Raynaud's phenomenon
38. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
39. Changes in cold induced vasodilatation during Arctic exercises
40. Observation upon the reactions of the vessels of the human skin to cold
41. Total and capillary finger blood flow in the finger, especially in cold induced vasodilatation
42. Lumped parameter tissue temperature-blood perfusion model of a cold stressed finger
43. Quantification of conservative endurance times in thermally insulated cold stressed digits
44. On the thermal efficiency of cold-stressed finger
45. Simulation of hand cooling due to touching cold materials
46. Parametric studies of human thermal mechanisms and measurements
47. Efficiency function: Improvement of classical bioheat approach
48. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders
49. Morphological changes in the digital arteries of patients with progressive systemic sclerosis and Raynaud Phenomenon
50. Pattern of finger capillary abnormalities in connective tissues disease by "wide-field" microscopy
51. CD23 and CD69 expression on human neutrophils of healthy subjects and patients with peripheral occlusive disease
52. Effects of 50 Hz sinusoidal electromagnetic fields on MCP-1 and RANTES generated from activated human macrophages
53. Anti-endothelial cell reactivity, the unresolved enigma
54. Gamma rays total body irradiation effects on the immune system of BALB/c mice: An immunopharmacological model for radioprotection study